/Companies

Arthex Biotech

6 known investors

Find your way into Arthex Biotech

Sign up to see every warm intro you have to Arthex Biotech

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Arthex Biotech team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Arthex Biotech develops antisense RNA compounds to treat diseases with unmet medical needs. The company focuses on microRNA-based therapeutic interventions.

Founders & leadership

BLBeatriz Llamusí
Beatriz LlamusíChief Scientific Officer & Co-FounderBeatriz Llamusí holds a Ph.D. in Biochemistry from the University Miguel Hernández and spent 13 years as a postdoctoral researcher in the Department of Genetics investigating rare neuromuscular diseases. She co-founded Arthex Biotech in 2019 to develop antisense RNA therapeutics and served as CEO until 2023, when she transitioned to Chief Scientific Officer.

Investors · 6

Frequently asked questions

What does Arthex Biotech do?
Arthex Biotech develops antisense RNA compounds to treat diseases with unmet medical needs. The company focuses on microRNA-based therapeutic interventions.
Who founded Arthex Biotech?
Arthex Biotech was founded by Beatriz Llamusí.
Who are Arthex Biotech's investors?
Arthex Biotech's investors include Hadean Ventures, Sound Bioventures, Bpifrance, Columbus Venture Partners, AdBio partners, Invivo Capital Partners.